6Long-Term Outlook
In general, the long-term outlook for those with AML-M5 is not fully understood. Nevertheless, we know that the condition tends to progress quickly if left untreated. When the body produces too much differentiation inhibitory factor, the long-term outlook might be grim. Also, around 40 percent of cases have a mutated Flt3 gene, which would be linked to a less promising outcome as well.
In a recent study, scientists have found that the overall survival rate in people with AML-M5 was around 46 percent in the next 5 years. More research is being done to find the best treatment options for this disease. It seems that the survival rate tends to improve over time. [9]















